Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: the clot she developed has brought about her passing this morning; unwell; This is a spontaneous report from a contactable consumer or other non hcp. A 67-year-old female patient received first dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number: EL7834; Expiration Date: not provided), via intramuscular, administered in arm on 09Feb2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. On 12Feb2021, 3 days after vaccine the patient began to feel unwell, diagnosed clot and sent to hospital. After several days on ward with oxygen no improvement so transferred into critical care. After all attempts nothing could be done. The patient was hospitalized for 10 days. Therapeutic measures were taken prescribed two courses of Antibiotics over phone by GP, deteriorated during and after the two courses. As a result of the clot she developed has brought about her passing this morning, unwell. The patient died on 14Apr2021. An autopsy was not performed. The reported cause of death was the clot she developed has brought about her passing this morning. The outcome of event was fatal and not recovered/not resolved.; Reported Cause(s) of Death: the clot she developed has brought about her passing this morning
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166